title: Evaluation of five simple rapid HIV assays for potential use in the Brazilian national HIV testing algorithm.
abstract: Since 2005, the Department of Sexually Transmitted Diseases (STDs), Acquired Immunodeficiency Syndrome (AIDS) and Viral Hepatitis under the Health Surveillance Secretariat in Brazil's Ministry of Health has approved a testing algorithm for using rapid human immunodeficiency virus (HIV) tests in the country. Given the constant emergence of new rapid HIV tests in the market, it is necessary to maintain an evaluation program for them. Conscious of this need, this multicenter study was conducted to evaluate five commercially available rapid HIV tests used to detect anti-HIV antibodies in Brazil. The five commercial rapid tests under assessment were the VIKIA HIV-1/2 (bioMérieux, Rio de Janeiro, Brazil), the Rapid Check HIV 1 & 2 (Center of Infectious Diseases, Federal University of Espírito Santo, Vitória, Brazil), the HIV-1/2 3.0 Strip Test Bioeasy (S.D., Kyonggi-do, South Korea), the Labtest HIV (Labtest Diagnóstica, Lagoa Santa, Brazil) and the HIV-1/2 Rapid Test Bio-Manguinhos (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil). A total of 972 whole-blood samples were collected from HIV-infected patients, pregnant women and individuals seeking voluntary counselling and testing who were recruited from five centers in different regions of the country. Informed consent was obtained from the study participants. The results were compared with those obtained using the HIV algorithm used currently in Brazil, which includes two enzyme immunoassays and one Western blot test. The operational performance of each assay was also compared to the defined criteria. A total of 972 samples were tested using reference assays, and the results indicated 143 (14.7%) reactive samples and 829 (85.3%) nonreactive samples. Sensitivity values ranged from 99.3 to 100%, and specificity was 100% for all five rapid tests. All of the rapid tests performed well, were easy to perform and yielded high scores in the operational performance analysis. Three tests, however, fulfilled all of the prerequisites established previously by the Department of STDs, AIDS and Viral Hepatitis: the HIV-1/2 3.0 Strip Test Bioeasy, the Rapid Check HIV 1 & 2 and the VIKIA HIV-1/2. Three of the five tests evaluated (the HIV-1/2 3.0 Strip Test Bioeasy, the Rapid Check HIV 1 and 2 and the VIKIA HIV-1/2) performed as well as the reference assays and fulfilled the requirements for use in the Brazilian national algorithm.
authors.affiliation: Laboratório de Pesquisa em HIV/AIDS, Centro de Ciências da Saúde, Universidade de Caxias do Sul, Rua Francisco Getúlio Vargas, 1130 - Bloco S - Sala 315, Caxias do Sul, RS 95070-560, Brazil. Electronic address: lrmotta@ucs.br.
authors.forename: Leonardo Rapone
authors.initials: LR
authors.lastname: da Motta
authors.forename: Andréa Cristina
authors.initials: AC
authors.lastname: Vanni
authors.forename: Sérgio Kakuta
authors.initials: SK
authors.lastname: Kato
authors.forename: Luiz Gustavo dos Anjos
authors.initials: LG
authors.lastname: Borges
authors.forename: Rosa Dea
authors.initials: RD
authors.lastname: Sperhacke
authors.forename: Rosangela Maria M
authors.initials: RM
authors.lastname: Ribeiro
authors.forename: Lilian Amaral
authors.initials: LA
authors.lastname: Inocêncio
mesh_terms: D001938:Brazil; D019411:Clinical Laboratory Techniques / Q000379:methods*; D003955:Diagnostic Tests, Routine / Q000379:methods*; D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000175:diagnosis*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D011247:Pregnancy; D012680:Sensitivity and Specificity
chemical_list: D015483:HIV Antibodies
keywords: HIV diagnosis; HIV-1; HIV-2; Immune assays